Home Applications 218033 Application 218033
Type NDA
Sponsor DAY ONE BIOPHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 OJEMDA TOVORAFENIB FOR SUSPENSION;ORAL 25MG/ML Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218033-001 OJEMDA TOVORAFENIB 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 N218033-001 10426782 2035-06-23 Drug product 2024-05-08
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N218033-001 NCE 2029-04-23 N218033-001 ODE-478 2031-04-23
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 8072bd15b7f6…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218033-001 OJEMDA 25MG/ML FOR SUSPENSION / ORAL RLD, RS 2024-04-23 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 8072bd15b7f6…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218033-001 8293752 2031-08-04 Drug substance, Drug product 2024-05-08 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218033-001 10426782 2035-06-23 Drug product 2024-05-08 a50c72e98297…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join OJEMDA TOVORAFENIB Day One Biopharmaceuticals, Inc. ea3a9631-3a66-6a7c-e053-2995a90ae2ad 2025-09-02 Warnings, Adverse reactions Exact identifier application applno (NDA): 218033 application number: NDA218033
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 83233 SUPPL 2025-08-29 83232 SUPPL 2025-08-29 83221 SUPPL 2025-08-28 83220 SUPPL 2025-08-28 78919 SUPPL 2024-06-27 78912 SUPPL 2024-06-27 78554 ORIG 2024-05-24 78538 ORIG 2024-05-22 78535 ORIG 2024-05-22